Odey Asset Management Group LTD Decreased Royal Caribbean Cruises LTD (RCL) Position By $1.89 Million; Flexion Therapeutics Has 1.22 Sentiment

January 14, 2018 - By Dolores Ford

Odey Asset Management Group Ltd decreased Royal Caribbean Cruises Ltd (RCL) stake by 39.02% reported in 2017Q3 SEC filing. Odey Asset Management Group Ltd sold 16,000 shares as Royal Caribbean Cruises Ltd (RCL)’s stock rose 11.49%. The Odey Asset Management Group Ltd holds 25,000 shares with $2.96M value, down from 41,000 last quarter. Royal Caribbean Cruises Ltd now has $27.30B valuation. The stock increased 1.69% or $2.12 during the last trading session, reaching $127.53. About 1.52 million shares traded or 5.13% up from the average. Royal Caribbean Cruises Ltd. (NYSE:RCL) has risen 38.22% since January 14, 2017 and is uptrending. It has outperformed by 21.52% the S&P500.

Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. The company has market cap of $992.95 million. It lead product candidate includes Zilretta, a late-stage, intra-articular, extended-release investigational steroid treatment that has completed Phase 3 clinical trials for IA therapy for patients with moderate and severe osteoarthritis pain. It currently has negative earnings.

Investors sentiment decreased to 1.25 in Q3 2017. Its down 0.01, from 1.26 in 2017Q2. It dived, as 39 investors sold RCL shares while 168 reduced holdings. 83 funds opened positions while 175 raised stakes. 153.19 million shares or 1.72% more from 150.60 million shares in 2017Q2 were reported. Legal General Grp Inc Public Limited Company reported 845,933 shares. First Bancorp Of Omaha reported 0.35% of its portfolio in Royal Caribbean Cruises Ltd. (NYSE:RCL). Landscape Mgmt Ltd holds 0.63% or 53,252 shares. Boston Private Wealth Ltd holds 0.79% or 173,842 shares. Aperio Gru Ltd has invested 0.04% of its portfolio in Royal Caribbean Cruises Ltd. (NYSE:RCL). New York-based Rockefeller has invested 2.67% in Royal Caribbean Cruises Ltd. (NYSE:RCL). Whittier Of Nevada has invested 0.01% in Royal Caribbean Cruises Ltd. (NYSE:RCL). Invesco Limited invested 0.18% in Royal Caribbean Cruises Ltd. (NYSE:RCL). Parkside Bank Tru stated it has 245 shares or 0.01% of all its holdings. Wolverine Asset Mgmt Lc has 0% invested in Royal Caribbean Cruises Ltd. (NYSE:RCL). Thomas White Intll holds 0.26% or 12,435 shares in its portfolio. Ajo Lp owns 213,759 shares. Dana Advsr owns 0.88% invested in Royal Caribbean Cruises Ltd. (NYSE:RCL) for 160,913 shares. Beach Invest Counsel Pa has 45,190 shares for 0.56% of their portfolio. Usa Fincl Portformulas Corporation reported 0.99% of its portfolio in Royal Caribbean Cruises Ltd. (NYSE:RCL).

Since August 2, 2017, it had 0 insider buys, and 10 insider sales for $53.70 million activity. Shares for $1.81M were sold by Bayley Michael W on Thursday, December 14. Fain Richard D had sold 20,000 shares worth $2.51 million. The insider Kulovaara Harri U sold $906,644. 120,000 Royal Caribbean Cruises Ltd. (NYSE:RCL) shares with value of $14.19 million were sold by Goldstein Adam M. 17,000 shares were sold by Pimentel Lawrence R, worth $2.05M. 4,793 shares were sold by REITAN BERNT, worth $561,827.

Among 23 analysts covering Royal Caribbean Cruises Ltd. (NYSE:RCL), 16 have Buy rating, 1 Sell and 6 Hold. Therefore 70% are positive. Royal Caribbean Cruises Ltd. had 60 analyst reports since August 3, 2015 according to SRatingsIntel. Morgan Stanley maintained the shares of RCL in report on Thursday, May 26 with “Equal-Weight” rating. Zacks upgraded Royal Caribbean Cruises Ltd. (NYSE:RCL) rating on Wednesday, August 5. Zacks has “Hold” rating and $100 target. Wedbush maintained Royal Caribbean Cruises Ltd. (NYSE:RCL) on Friday, January 27 with “Outperform” rating. The firm has “Neutral” rating by JP Morgan given on Thursday, October 27. Buckingham Research maintained the stock with “Buy” rating in Wednesday, November 8 report. Berenberg upgraded the shares of RCL in report on Thursday, January 11 to “Buy” rating. As per Friday, October 13, the company rating was maintained by SunTrust. The company was maintained on Wednesday, November 8 by Deutsche Bank. The stock has “Buy” rating by Stifel Nicolaus on Wednesday, September 6. Nomura maintained Royal Caribbean Cruises Ltd. (NYSE:RCL) rating on Wednesday, August 2. Nomura has “Buy” rating and $135 target.

Analysts await Royal Caribbean Cruises Ltd. (NYSE:RCL) to report earnings on January, 25. They expect $1.20 earnings per share, down 2.44% or $0.03 from last year’s $1.23 per share. RCL’s profit will be $256.91 million for 26.57 P/E if the $1.20 EPS becomes a reality. After $3.49 actual earnings per share reported by Royal Caribbean Cruises Ltd. for the previous quarter, Wall Street now forecasts -65.62% negative EPS growth.

Gagnon Advisors Llc holds 1.99% of its portfolio in Flexion Therapeutics, Inc. for 108,498 shares. Kingdon Capital Management L.L.C. owns 883,321 shares or 1.39% of their US portfolio. Moreover, Gilder Gagnon Howe & Co Llc has 1.35% invested in the company for 3.96 million shares. The New York-based Gagnon Securities Llc has invested 1.25% in the stock. Scholtz & Company Llc, a Connecticut-based fund reported 55,250 shares.

The stock increased 1.81% or $0.47 during the last trading session, reaching $26.45. About 685,720 shares traded. Flexion Therapeutics, Inc. (FLXN) has risen 82.02% since January 14, 2017 and is uptrending. It has outperformed by 65.32% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>